Eagle Capital Growth Fund (GRF) 7.82 $GRF
Grifols Opens Diagnostic Training Center in Dubai
PR Newswire Europe - Sat Sep 17, 6:38AM CDT
- The new center, part of Grifols growing Diagnostic business, will train laboratory technicians, engineers, and specialists on Grifols systems and laboratory best practices.
GRF: 7.82 (-0.14), GRFS: 16.29 (+0.03)
Singulex announces a $50 million investment by Grifols for a 20% stake in the company
PR Newswire - Tue May 31, 7:26AM CDT
Singulex, Inc., the leader in next generation immunodiagnostic technology powered by single molecule counting, announced today a partnership with Grifols, one of the world's largest plasma product manufacturers and a pioneer in the research and development of therapeutic alternatives designed to contribute to scientific development. Grifols has subscribed a share capital increase and holds a 20% stake in Singulex. The partnership provides Singulex US$50 million in exchange for Grifols' access to an exclusive worldwide license for the use and sale of Singulex' SMC technology for the screening of donor blood and plasma. Grifols' investment marks a major advancement in further ensuring the safety of blood and plasma products.
GRF: 7.82 (-0.14), GRFS: 16.29 (+0.03)
Eagle Capital Growth Fund finalizes year-end distribution
M2 - Tue Jan 05, 5:18AM CST
Eagle Capital Growth Fund, Inc. (NYSE: GRF) said it has finalized its year-end distribution of USD0.50 per share. The fund offered shareholders the choice of receiving the distribution in newly-issued shares of the fund's common stock or receiving the distribution in cash. The fund issued 138,190 shares of common stock at a price of USD7.14 per share, and paid out approximately USD575,887 in cash to shareholders. On a preliminary basis, this distribution represents a combination of net investment income of USD0.1791 per share and long-term capital gains of USD0.3209 per share. The fund is a closed-end investment company that invests primarily in high quality growth companies.
GRF: 7.82 (-0.14)
Eagle Capital Growth Fund announces final year end distribution of USD0.50 per share
M2 - Wed Dec 30, 3:47AM CST
The Eagle Capital Growth Fund Inc (NYSE MKT:GRF) finalised its year-end distribution of USD0.50 per share, it reported on Wednesday.
GRF: 7.82 (-0.14)
Eagle Capital Growth Fund Declares Year-End Distribution of $0.50 Per Share
BusinessWire - Mon Nov 09, 3:05PM CST
The Eagle Capital Growth Fund, Inc. ("Fund"
(NYSE MKT: GRF) today declared a year-end distribution of $0.50 per share. The record date for this distribution is November 23, 2015, and the payment date is December 28, 2015.
GRF: 7.82 (-0.14)
Eagle Capital Growth Fund announces distribution of USD0.37 per share for year end
M2 - Tue Dec 02, 6:57AM CST
Closed-end investment company, the Eagle Capital Growth Fund Inc (NYSE MKT:GRF), disclosed on Tuesday that it will pay a cash distribution of USD0.37 per share for the year-end, representing a combination of net investment income of USD0.022 per share and long-term capital gains of USD0.348 per share.
GRF: 7.82 (-0.14)
Grifols Opens Diagnostic Training Center in Dubai
PR Newswire Europe - Sat Sep 17, 6:38AM CDT
- The new center, part of Grifols growing Diagnostic business, will train laboratory technicians, engineers, and specialists on Grifols systems and laboratory best practices.
GRF: 7.82 (-0.14), GRFS: 16.29 (+0.03)
Singulex announces a $50 million investment by Grifols for a 20% stake in the company
PR Newswire - Tue May 31, 7:26AM CDT
Singulex, Inc., the leader in next generation immunodiagnostic technology powered by single molecule counting, announced today a partnership with Grifols, one of the world's largest plasma product manufacturers and a pioneer in the research and development of therapeutic alternatives designed to contribute to scientific development. Grifols has subscribed a share capital increase and holds a 20% stake in Singulex. The partnership provides Singulex US$50 million in exchange for Grifols' access to an exclusive worldwide license for the use and sale of Singulex' SMC technology for the screening of donor blood and plasma. Grifols' investment marks a major advancement in further ensuring the safety of blood and plasma products.
GRF: 7.82 (-0.14), GRFS: 16.29 (+0.03)
Eagle Capital Growth Fund finalizes year-end distribution
M2 - Tue Jan 05, 5:18AM CST
Eagle Capital Growth Fund, Inc. (NYSE: GRF) said it has finalized its year-end distribution of USD0.50 per share. The fund offered shareholders the choice of receiving the distribution in newly-issued shares of the fund's common stock or receiving the distribution in cash. The fund issued 138,190 shares of common stock at a price of USD7.14 per share, and paid out approximately USD575,887 in cash to shareholders. On a preliminary basis, this distribution represents a combination of net investment income of USD0.1791 per share and long-term capital gains of USD0.3209 per share. The fund is a closed-end investment company that invests primarily in high quality growth companies.
GRF: 7.82 (-0.14)
Eagle Capital Growth Fund announces final year end distribution of USD0.50 per share
M2 - Wed Dec 30, 3:47AM CST
The Eagle Capital Growth Fund Inc (NYSE MKT:GRF) finalised its year-end distribution of USD0.50 per share, it reported on Wednesday.
GRF: 7.82 (-0.14)
Eagle Capital Growth Fund Declares Year-End Distribution of $0.50 Per Share
BusinessWire - Mon Nov 09, 3:05PM CST
The Eagle Capital Growth Fund, Inc. ("Fund"
(NYSE MKT: GRF) today declared a year-end distribution of $0.50 per share. The record date for this distribution is November 23, 2015, and the payment date is December 28, 2015. GRF: 7.82 (-0.14)
Eagle Capital Growth Fund announces distribution of USD0.37 per share for year end
M2 - Tue Dec 02, 6:57AM CST
Closed-end investment company, the Eagle Capital Growth Fund Inc (NYSE MKT:GRF), disclosed on Tuesday that it will pay a cash distribution of USD0.37 per share for the year-end, representing a combination of net investment income of USD0.022 per share and long-term capital gains of USD0.348 per share.
GRF: 7.82 (-0.14)
